h5n1

Documents about h5n1

• Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses#1444126ClinicalTrials.gov
• Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1#1432786ClinicalTrials.gov
• Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults#1125836ClinicalTrials.gov
• Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children#882029ClinicalTrials.gov
• Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults#1496277ClinicalTrials.gov
• A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 Influenza Vaccine#1151312ClinicalTrials.gov
• H5N1 Vaccine Study in Japanese Adults#834783ClinicalTrials.gov
• Mechanistic modelling of highly pathogenic avian influenza: A scoping review revealing critical gaps in cross-species transmission models#146564PLOS
• Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49#1244018ClinicalTrials.gov
• Host Genetic Susceptibility to Avian Influenza A/H5N1#1032806ClinicalTrials.gov
• Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 Influenza Vaccines Containing 2 Doses of H5N1 Influenza Antigen, in Non-elderly Adult and Elderly Subjects#844491ClinicalTrials.gov
• Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine#1075164ClinicalTrials.gov
• H5N1 Mix and Match With MF59#886929ClinicalTrials.gov
• A/H5N1 Dose Ranging Study With Adjuvant Patch#1376534ClinicalTrials.gov
• H5N1 Mix and Match With AS03#1452247ClinicalTrials.gov
• Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant#1259216ClinicalTrials.gov
• Data and code for "Predicting high pathogenicity avian influenza H5N1 susceptibility in wild birds"#202125Figshare
• H5N1 Priming and Boosting Strategies#864017ClinicalTrials.gov
• Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years#1420609ClinicalTrials.gov
• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults#1047166ClinicalTrials.gov
• Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects#1127443ClinicalTrials.gov
• Prospective Study of AI H5N1 in China#908067ClinicalTrials.gov
• Inactivated Influenza A/H5N1 Vaccine in the Elderly#1409917ClinicalTrials.gov
• H5N1 Vaccination With and Without AS03: Systems Biology Analysis#1430100ClinicalTrials.gov
• Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine#1462656ClinicalTrials.gov
• Mapping Reported Modes of Transmission of Highly Pathogenic Avian Influenza A (H5N1) to Humans: A Scoping Review#642267Europe PMC
• Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)#1138159ClinicalTrials.gov
• Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine#869487ClinicalTrials.gov
• cmmid/h5n1_uk_scenario_model#231916LSHTM Data Compass
• Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed Adults#1031423ClinicalTrials.gov
• cmmid/h5n1_uk_scenario_modelling#231920LSHTM Data Compass
• Data Sheet 1_Methods for detecting highly pathogenic avian influenza H5N1 virus in dairy processing environments.docx#253478Figshare
• A/H5N1/LT Dose Ranging Study#1477896ClinicalTrials.gov
• The role of wild waterbird in spreading avian influenza virus subtype H5N1 at Pulau Dua Nature Reverse#257840IPB Scientific Repository
• Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults#1296003ClinicalTrials.gov
• Safety, Reactogenicity and Immunogenicity of an H5N1 VLP#1075510ClinicalTrials.gov
• Highly Pathogenic Avian Influenza H5N1 in South America, 2022-2025: Spread, Affected Species, and Southward Expansion into the Antarctic Region#651901Europe PMC
• Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children#993897ClinicalTrials.gov
• Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children#1372069ClinicalTrials.gov
• A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults#1397890ClinicalTrials.gov
• Obat Herbal dari Akar Manis (Glycyrrhiza glabra L.) untuk Pencegahan dan Pengobatan Infeksi Virus H1N1, H5N1 dan COVID-19: Systematic Review: Herbal Drug from Sweet Root (Glycyrrhiza glabra L.) for Prevention and Treatment of H1N1, H5N1 and COVID-19 Virus Infections: Systematic Review#1003836Jurnal Surya Medika (JSM)
• Safety Study of Avian Flu Vaccine#1408063ClinicalTrials.gov
• Study of a Parenterally Administered H5N1 Influenza Vaccine in Healthy Adults#405209ClinicalTrials.gov
• Diagnóstico etiológico sobre a gripe aviária em montenegro no rio grande do sul: Análise integrada de patogenicidade e instrumentos de propriedade intelectual#311216DIALNET OAI Articles
• Dispersal, adaptation and persistence of H5N1 in the sub-Antarctic and Antarctica#143839bioRxiv / medRxiv
• Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age#148558ClinicalTrials.gov
• PERSONAL PROTECTIVE EQUIPMENT FOR INFLUENZA A(H5N1) IN HIGH-RISK FARM SETTINGS: A WORKSHOP#250832NCBI Bookshelf
• A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1#1352322ClinicalTrials.gov
• Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children#373653ClinicalTrials.gov
• Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents#390961ClinicalTrials.gov